CF
53
2
HES
52
2
TDC
44
3
COST
48
3
CVS
45
-2
AON
50
-13
BAC
51
-2
AMAT
52
2
IRM
52
6
FOXA
55
2
SPG
51
3
NI
70
2
MUR
31
2
K
66
-2
PYPL
41
-9
XRAY
31
2
CCI
26
9
URBN
58
2
IPG
48
6
ADP
66
-2
CF
53
2
HES
52
2
TDC
44
3
COST
48
3
CVS
45
-2
AON
50
-13
BAC
51
-2
AMAT
52
2
IRM
52
6
FOXA
55
2
SPG
51
3
NI
70
2
MUR
31
2
K
66
-2
PYPL
41
-9
XRAY
31
2
CCI
26
9
URBN
58
2
IPG
48
6
ADP
66
-2
Financhill
Back

Matinas BioPharma Holdings Vs. Charles River Laboratories International Industry Stock Comparison

Sell
38

MTNB
Matinas BioPharma Holdings

Last Price:
$0.63
Seasonality Move:
-18.9%
Sell
34

CRL
Charles River Laboratories International

Last Price:
$114.68
Seasonality Move:
5.51%
Sell
38
Matinas BioPharma Holdings (MTNB) is a Sell

Is Matinas BioPharma Holdings a Buy, Sell or Hold?

  • The current Matinas BioPharma Holdings [MTNB] share price is $0.67. The Score for MTNB is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • MTNB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
34
Charles River Laboratories International (CRL) is a Sell

Is Charles River Laboratories International a Buy, Sell or Hold?

  • The current Charles River Laboratories International [CRL] share price is $114.66. The Score for CRL is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • CRL is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

MTNB Stock Price Chart

What is Matinas BioPharma Holdings's stock price today?

  • The Matinas BioPharma Holdings share price today is $0.67
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MTNB is experiencing buying pressure, which is a positive indicator for future bullish movement.

CRL Stock Price Chart

What is Charles River Laboratories International's stock price today?

  • The Charles River Laboratories International share price today is $114.66
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRL is experiencing buying pressure, which is a positive indicator for future bullish movement.

MTNB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.01 Buy
Relative Strength Index (14 RSI): 64.51 Buy
Chaikin Money Flow: 112759 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.54 - 0.6) Buy
Bollinger Bands (100): (0.52 - 0.64) Buy

CRL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 7.84 Buy
Relative Strength Index (14 RSI): 39.88 Sell
Chaikin Money Flow: 948554 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (106.99 - 153.77) Sell
Bollinger Bands (100): (138.71 - 190.39) Sell

MTNB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.59 Buy
20-day SMA: 0.56 Buy
50-day SMA: 0.57 Buy
200-day SMA: 2.48 Sell
8-day EMA: 0.6 Buy
20-day EMA: 0.58 Buy
50-day EMA: 0.6 Buy
200-day EMA: 2.77 Sell

CRL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 108.15 Buy
20-day SMA: 122.37 Sell
50-day SMA: 147.81 Sell
200-day SMA: 183.4 Sell
8-day EMA: 111.42 Buy
20-day EMA: 109.48 Buy
50-day EMA: 81.15 Buy
200-day EMA: 29.79 Buy

Matinas BioPharma Holdings Earnings Growth & MTNB Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.56 per share, and a decrease next year of $2.50 per share.

Charles River Laboratories International Earnings Growth & CRL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.03 per share, a decrease this year of $0.87 per share, and an increase next year of $0.77 per share.

Matinas BioPharma Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Charles River Laboratories International Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):